Wird geladen...
Histologic transformation of lung cancer during pembrolizumab therapy: A case report
Immune checkpoint inhibitors that block the programmed death 1/programmed death ligand 1 pathways are widely used to treat advanced lung cancers. There are seldom cases of histologic transformation reported after treatment with immunotherapy. Here, we report the case of a 69‐year‐old man with stage...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2020-03-01
|
| Schriftenreihe: | Thoracic Cancer |
| Schlagworte: | |
| Online Zugang: | https://doi.org/10.1111/1759-7714.13312 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|